Nautilus Biotechnology, Inc
Price
FilingsNewest: 424B5, Offering prospectusSep 18 →Insiders2 insiders bought $71,210 in 2 open-market buys. 6 insiders sold $11.8M, 0 of 2 sales on a 10b5-1 plan.→HoldersPerceptive 9.1%a16z 7.1%Cercano 5.6%→Financing →PeersClosest companies: QSI, BNGO, OABI→
From the filings
Figures
- Net income
- −$56.5Mlast 12 months
- Operating cash flow
- −$49.9Mlast 12 months
- Cash and equivalents
- $13.2Mat the last balance sheet
- Shares outstanding
- 127.2M shareson issue